Incorporated in 2004, Ami Organics Limited is one of the leading research and development driven manufacturers of specialty chemicals. The company manufactures different types of Advanced Pharmaceutical Intermediates and Active Pharmaceutical ingredients (API) for New Chemical Entities, and material for agrochemicals and fine chemicals.
The company has developed over 450 pharma intermediates across 17 key therapeutic areas i.e. anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson, anti-depressant, and anti-coagulant. It supplies its products to more than 150 customers (including international customers) directly in India and in 25 countries overseas i.e. Europe, USA, China, Israel, Japan, Latin America, etc. Laurus Labs, Cadila Healthcare, Cipla Ltd are some of the domestic customers whereas Organike s.r.l.a. Socio Unico, Fermion Oly, Medichem S.A. and Midas Pharma GmbH are some of the international customers.
The company has three manufacturing facilities in Gujarat situated at Sachin, Ankleshwar & Jhagadia, with an aggregate installed capacity of 6,060 MTPA.
- One of the leading manufacturers of certain Pharma Intermediates i.e. Dolutegravir, Trazodone, Entacapone, Nintedanib and Rivaroxaban.
- Strong and diversified product portfolio with 450+ Pharma Intermediates across 17 therapeutic areas.
- Extensive geographical presence and diversified customer base.
- Strong R&D, sales and marketing capabilities
- Consistent financial performance track record.
Nareshkumar Ramjibhai Patel, Chetankumar Chhaganlal Vaghasia, Shital Nareshbhai Patel and Parul Chetankumar Vaghasia are the company promoters
|Particulars||For the year/period ended (₹ in Millions)|
|Profit After Tax||539.99||274.7||232.95|
Objects of the Issue:
- Repayment/prepayment of certain financial facilities availed by our Company.
- Funding working capital requirements of our Company.
- General corporate purposes.
Ami Organics IPO Details
|IPO Opening Date||Sep 1, 2021|
|IPO Closing Date||Sep 3, 2021|
|Issue Type||Book Built Issue IPO|
|Face Value||₹10 per equity share|
|IPO Price||₹603 to ₹610 per equity share|
|Market Lot||24 Shares|
|Min Order Quantity||24 Shares|
|Listing At||BSE, NSE|
|Issue Size||[.] Eq Shares of ₹10
(aggregating up to ₹569.64 Cr)
|Fresh Issue||[.] Eq Shares of ₹10
(aggregating up to ₹200.00 Cr)
|Offer for Sale||6,059,600 Eq Shares of ₹10
(aggregating up to ₹369.64 Cr)
Ami Organics IPO Tentative Timetable
The Ami Organics IPO open date is Sep 1, 2021, and the close date is Sep 3, 2021. The issue may list on Sep 14, 2021.
|IPO Open Date||Sep 1, 2021|
|IPO Close Date||Sep 3, 2021|
|Basis of Allotment Date||Sep 8, 2021|
|Initiation of Refunds||Sep 9, 2021|
|Credit of Shares to Demat Account||Sep 13, 2021|
|IPO Listing Date||Sep 14, 2021|
Ami Organics IPO Lot Size
The Ami Organics IPO market lot size is 24 shares. A retail-individual investor can apply for up to 13 lots (312 shares or ₹190,320).
Ami Organics IPO Promoter Holding
|Pre Issue Share Holding||47.23%|
|Post Issue Share Holding||41.05%|
Ami Organics IPO Subscription Status (Bidding Detail)
The Ami Organics IPO is subscribed 0.35x times on Sep 1, 2021 10:48. The public issue subscribed 0.69x in the retail category, 0.00x in the QIB category, and 0.00x in the NII category.
Company Contact Information
Plot No. 440/4, 5 & 6, Road No. 82/A
GIDC Sachin, Surat – 394 230
Phone: +91 261 239 7193
Email: [email protected]
Ami Organics IPO Registrar
Phone: +91-22-4918 6270
Email: [email protected]